The American College of Rheumatology applauded Congressional lawmakers for providing a $10 million annual line item for arthritis research in the recently passed $886 billion national defense bill.According to the ACR, the inclusion marks the first new medical research...
The American College of Rheumatology applauded Congressional lawmakers for providing a $10 million annual line item for arthritis research in the recently passed $886 billion national defense bill.
According to the ACR, the inclusion marks the first new medical research line item in the Congressionally Directed Medical Research Program (CDMRP) in 8 years. The U.S. House of Representatives approved the final version of the National Defense Authorization Act (NDAA) for the fiscal year 2024 on Dec. 14, clearing the way for President Joe Biden to sign it into law.
“Investment in arthritis
